These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 20687888)

  • 1. Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.
    Giralt M; Díaz-Delfín J; Gallego-Escuredo JM; Villarroya J; Domingo P; Villarroya F
    Curr Pharm Des; 2010 Oct; 16(30):3371-8. PubMed ID: 20687888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of metabolic toxicity of HIV antiretroviral drugs: the multiple roads to lipodystrophy and metabolic syndrome.
    Domingo P; Villarroya F
    Curr Pharm Des; 2010 Oct; 16(30):3337-8. PubMed ID: 20687885
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.
    Villarroya F; Domingo P; Giralt M
    Biochim Biophys Acta; 2010 Mar; 1801(3):392-9. PubMed ID: 19800025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations.
    Caron-Debarle M; Boccara F; Lagathu C; Antoine B; Cervera P; Bastard JP; Vigouroux C; Capeau J
    Curr Pharm Des; 2010 Oct; 16(30):3352-60. PubMed ID: 20687886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of inflammation to fat redistribution and metabolic disturbances in HIV-1 infected patients.
    Stankov MV; Behrens GM
    Curr Pharm Des; 2010 Oct; 16(30):3361-71. PubMed ID: 20687889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue biology and HIV-infection.
    Giralt M; Domingo P; Villarroya F
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):487-99. PubMed ID: 21663842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophy in HIV 1-infected patients: lessons for obesity research.
    Villarroya F; Domingo P; Giralt M
    Int J Obes (Lond); 2007 Dec; 31(12):1763-76. PubMed ID: 17653062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.
    Flint OP; Noor MA; Hruz PW; Hylemon PB; Yarasheski K; Kotler DP; Parker RA; Bellamine A
    Toxicol Pathol; 2009 Jan; 37(1):65-77. PubMed ID: 19171928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.
    Lagathu C; Kim M; Maachi M; Vigouroux C; Cervera P; Capeau J; Caron M; Bastard JP
    Biochimie; 2005 Jan; 87(1):65-71. PubMed ID: 15733739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy.
    Kovsan J; Osnis A; Maissel A; Mazor L; Tarnovscki T; Hollander L; Ovadia S; Meier B; Klein J; Bashan N; Rudich A
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E315-22. PubMed ID: 19033543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.
    Feeney ER; Mallon PW
    Curr Pharm Des; 2010 Oct; 16(30):3339-51. PubMed ID: 20687890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
    Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J
    Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
    Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
    Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the metabolic effects of HIV and HIV drugs.
    Brown TT; Glesby MJ
    Nat Rev Endocrinol; 2011 Sep; 8(1):11-21. PubMed ID: 21931374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    AIDS; 2002 Nov; 16(16):2183-93. PubMed ID: 12409740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
    Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
    Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.